After Hours Decliner
AARD Aardvark Therapeutics12.49-0.01-0.1%
After Hours:6.58-5.91 (-47.3%)
Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome
Globe NewswireFri, 27-Feb 4:05 PM
After Hours Decliner
AARD Aardvark Therapeutics12.49-0.01-0.1%
After Hours:5.99-6.50 (-52.0%)
Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome
Globe NewswireFri, 27-Feb 4:05 PM